8-KMaterial AgreementsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Material Agreement (Dec 27, 2004)

Filed December 27, 2004For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences Corp (EW) on December 27, 2004, primarily serves to disclose the adoption of the Edwards Lifesciences Corporation Executive Deferred Compensation Plan. While not containing detailed financial results or significant operational updates, this filing is important for understanding the company's executive compensation structure and its commitment to retaining key talent. Such plans are designed to offer long-term incentives and financial security to top executives, which can indirectly signal management's confidence and alignment with shareholder interests over the long haul. Investors should view this as a governance-related disclosure. The existence of a deferred compensation plan is standard practice for many publicly traded companies and is generally viewed positively as it can align executive interests with long-term company performance. However, it's crucial for investors to analyze the specifics of such plans, such as vesting schedules and payout provisions, when reviewing the full plan document to assess its potential impact on future cash flows and executive decision-making.

Key Highlights

  • 1Edwards Lifesciences Corp (EW) filed an 8-K on December 27, 2004.
  • 2The filing's primary purpose is the disclosure of a new executive compensation plan.
  • 3Exhibit 10.1 details the 'Edwards Lifesciences Corporation Executive Deferred Compensation Plan'.
  • 4This filing does not contain material financial statements or significant operational updates.
  • 5The disclosure relates to executive compensation and retention strategies.
  • 6Bruce P. Garren, Corporate Vice President and General Counsel, signed the filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally disclose the adoption of the Edwards Lifesciences Corporation Executive Deferred Compensation Plan, as required by SEC regulations for material events.

No, this particular 8-K filing does not include any new financial results, earnings reports, or significant operational updates. Its focus is solely on the executive deferred compensation plan.

Deferred compensation plans are important because they can affect executive retention, motivation, and alignment with long-term company performance. Understanding these plans helps investors assess the company's governance and executive incentive structures.

The full details of the 'Edwards Lifesciences Corporation Executive Deferred Compensation Plan' are available as Exhibit 10.1 to this 8-K filing, which can be accessed through the SEC's EDGAR database or the company's investor relations portal.